Graft Polymer’s new Slovenian plant key to unlocking industrial-scale solutions
–News Direct–
Welcome to Wednesday's business update. In this video, we focus on Graft Polymer (UK) PLC's milestonethe commissioning of its expanded Slovenian plant.
Chairman Roby Zomer says this new facility doubles the company's production capacity to 6,000 tonnes per year and opens doors for industrial-scale partnerships.
We'll also delve into the company's recent contract achievements, including a significant U.S. approval for its GraftBio drug delivery system. Where it has been approved for sale over-the- counter as a part of the MGC Pharma ArtemiC COVID treatment.
Stay tuned as we explore how these developments are setting the stage for Graft Polymer's future growth and market expansion. The core business of the group comprises polymer...